There is research on this stock available only to PRO subscribers.
From other sites
There are no Transcripts on LVCLY.
We currently have no Breaking News on this stock.
LVCLY vs. ETF Alternatives
Living Cell Technologies (LCT) is an Australasian biotechnology company and world leader in developing cell therapies to treat diseases with high unmet clinical need. To date, the company has taken two therapeutic candidates into clinical development: DIABECELL, for the treatment of type 1... More
Other News & PR